hero image
Jiang He - Tulane University. New Orleans, LA, US

Jiang He Jiang He

Professor and Chair | Tulane University

New Orleans, LA, UNITED STATES

Jiang He is an expert in public health, epidemiology, and clinical research.

Media

Publications:

Documents:

Photos:

loading image loading image loading image

Videos:

Audio:

Social

Biography

Professor, chair of the Department of Epidemiology, and Joseph S. Copes Chair of Epidemiology Jian He is a nationally and internationally known expert in the clinical, translational, and epidemiological research of cardiovascular and kidney diseases. He has conducted novel studies in obesity, hypertension, diabetes, stroke, cardiovascular disease, and chronic kidney disease funded by the National Institutes of Health. He has been the principal investigator and co-investigator for more than 30 major research awards from the National Institutes of Health worth more than 150 million U.S. dollars. Dr. He has authored over 400 scientific articles and has published in first class biomedical journals, including New England Journal of Medicine, Journal of The American Medical Association, Lancet, and National Genetics. He has received many awards from local, national, and international academic institutions and professional societies. He directs the Tulane University Translational Science Institute which promotes high-impact clinical, translational, and implementation research at Tulane University.

Areas of Expertise (11)

Coronavirus

Cardiovascular Disease Prevention

Gene-Environmental Interaction

Global Cardiovascular Disease Epidemiology

Clinical Research

Public Health

Epidemiology

Clinical Epidemiology

Clinical Trials and Implementation Sciences

Cardiometabolic diseases

COVID-19

Accomplishments (5)

Highly Cited Researchers (Clinical Medicine)

2014
Thomson Reuters

Oliver Fund Award for Excellence in Faculty Mentoring

2017
Tulane University

President's Award for Excellence in Research

Tulane University

Honorary Professor

Peking Union Medical College and Chinese Academy of Medical Sciences

Distinguished Alumnus Award

Johns Hopkins University

Education (4)

The Johns Hopkins University: Ph.D., Clinical Epidemiology

Jianxi Medical College: B.A., Clinical Medicine

Peking Union Medical College and Chinese Academy of Medical Sciences: M.D., Cardiovascular Disease Epidemiology

Tulane University: M.S.

Affiliations (2)

  • American College of Epidemiology
  • American Heart Association

Media Appearances (5)

Substance Use Ups Risks for CKD Progression, Mortality

Renal & Urology News  online

2018-06-12

In a multivariable adjusted model, persistent tobacco smoking was associated with a significant 1.9-fold increased risk of death compared with nonsmoking, Jiang He, MD, PhD, of Tulane University School of Public Health and Tropical Medicine, and colleagues reported. Persistent use of hard illicit drugs was associated with a significant 1.25- and 1.41-fold increased risk of CKD progression and death, respectively, compared with nonuse. Cocaine use was associated with a significant 2-fold increased risk of death. Heroin use was associated with a significant 1.6-fold increased risk of CKD progression...

view more

Keeping people within U.S. blood pressure guidelines saves lives

Science News  online

2018-05-29

But adhering to the guidelines means doctors may recommend that 83 million adults, 11 million more than before, take blood pressure medications. Those drugs carry a risk of side effects, including kidney damage or abnormally low blood pressure. Of those taking the drugs, 62,000 people’s blood pressure could dip too low and 79,000 might suffer kidney injury or failure, epidemiologist Jiang He of Tulane University in New Orleans and his colleagues estimate...

view more

Controversial 2017 hypertension guidelines could save 300K lives every year

Cardiovascular Business  online

2018-05-25

The researchers, led by first author Jiang He, MD, PhD, of Tulane University School of Public Health and Tropical Medicine in New Orleans sought to estimate the effects of both the 2017 and 2014 hypertension guidelines on proportions of adults defines as having high blood pressure or recommended for antihypertensive treatment and reductions in cardiovascular disease and mortality...

view more

Coronary Artery Calcification Risk Factors in CKD Identified

Renal & Urology News  online

2018-02-15

To understand why CAC is more common and severe in CKD patients, Jiang He, MD, PhD, of Tulane University School of Public Health and Tropical Medicine in New Orleans, and colleagues assessed CAC progression by computed tomography and Agatston measurements in 1123 racially and ethnically diverse patients (aged 21–74 years) with stage 2 to 4 CKD from the Chronic Renal Insufficiency Cohort (CRIC) study.

view more

BP Control Best Achieved With Multipronged Approach

Medscape  online

2018-01-09

The current analysis clearly demonstrates that "multicomponent strategies at health system, provider, and patient levels are essential for blood pressure control in patients with hypertension," Dr Jiang He (Tulane University, New Orleans, LA) told theheart.org | Medscape Cardiology...

view more

Articles (5)

Prevalence and Control of Diabetes in Chinese Adults JAMA Network

2013

Noncommunicable chronic diseases have become the leading causes of mortality and disease burden worldwide.

view more

Prevalence of Diabetes among Men and Women in China The New England Journal of Medicine

2010

Because of the rapid change in lifestyle in China, there is concern that diabetes may become epidemic. We conducted a national study from June 2007 through May 2008 to estimate the prevalence of diabetes among Chinese adults.

view more

Major Causes of Death among Men and Women in China New England Journal of Medicine

2005

With China's rapid economic development, the disease burden may have changed in the country. We studied the major causes of death and modifiable risk factors in a nationally representative cohort of 169,871 men and women 40 years of age and older in China.

view more

Global burden of hypertension: analysis of worldwide data The Lancet

2005

Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025.

view more

Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials Annals of Internal Medicine

2002

Physical activity has been associated with reduced blood pressure in observational epidemiologic studies and individual clinical trials. This meta-analysis of randomized, controlled trials was conducted to determine the effect of aerobic exercise on blood pressure.

view more